Posts

Showing posts with the label Api

Subscribe Now!

Government Initiatives to boost Growth for Indian Chemical Sector

Image
India's Growth Trajectory in Chemical Sector supported by Government Initiatives Twitter Handle: @shuchi_nahar The global chemicals market is valued at around USD 4,738 billion and is expected to grow at 6.2% CAGR reaching USD 6,400 billion by 2024. The Indian chemicals market is valued at USD 166 billion (~4% share in the global chemical industry) and it is expected to reach ~USD 280-300 Bn in the next 5 years, with an anticipated growth of ~12% CAGR. The specialty chemical industry forms ~47% of the domestic chemical market, which is expected to grow at a CAGR of around 11-12% over the same period. Stronger growth lead by Government Initiatives India’s growth story was largely positive based on the strength of domestic absorption and the economy was registering a steady pace of economic growth pre-Covid. Moreover, its other macroeconomic parameters like inflation, fiscal deficit and current account balance had exhibited distinct signs of improvement. Though the pandemic has l

Laurus Labs - Result Update Q4FY21 & Full Year FY21

Image
Laurus Labs - Result Update Q4FY21 & Full Year FY21 Twitter Handle: @shuchi_nahar Laurus Labs Limited on 30th April 2021 announced its Q4FY21 and full-year results.  Laurus Lab performed extremely well consecutive in the 4th Quarter of FY21. The company did a robust growth in all three segments. Having a healthy order book for FY 22. Consolidated revenue for the quarter increased by 70% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 297 Crs. for the quarter. Generic API division showcased a robust growth of 61% YoY. Anti Viral segment recorded a robust growth of 70% YoY. Revenue Showcased a healthy growth of 102% YoY. The growth was led by higher LMIC Market volumes and increased volumes from North America and EU Commenced marketing of in-licensed products in the USA to leverage front-end capabilities. Custom Synthesis division recorded a strong growth of 35% YoY. Capacity Expansion – To

PHARMA SECTOR PRIMER

  Your ultimate guide to understand the basics and details about the Indian Pharma Sector A Brief Understanding On Pharma Sector From Its Key Terms To Its Filing And Procedures. The following article is on the Indian Pharmaceutical Industry, the article is written to familiarize ourselves with the terminology or the jargon’s of the pharmaceutical industry. It will briefly touch upon terms like API, Intermediates, CDMO’s/ CRAM’s, PARA Filings,  Innovator drug, Generic drugs, life cycle development etc. The Indian pharmaceuticals market has characteristics that make it unique. First, branded generics dominate, making up for 70 to 80% of the retail market.  India also has the feather of being the  largest exporter of generic drugs  in the world.  Second, local players have enjoyed a dominant position driven by the formulation development capabilities and early investments.  Third, price levels are low, driven by intense competition. While India ranks tenth globally in terms of value, it

Neuland Labs Ltd - Q3FY21 Result Update

Image
Neuland Labs Ltd Q3FY21 Result Update Twitter Handle: @shuchi_nahar   Link to Company Overview of Neuland Labs in detail: https://myweekendspot.blogspot.com/2020/09/neuland-labs-company-snapshot.html The company has announced consecutive another strong quarter of top-line and bottom-line performance. The revenue at Rs.245.6 crores was a 20% improvement over the corresponding quarter of the last fiscal while the margins have shown an upward trajectory and closed at 19.0%. This was driven by growth across the GDS and CMS verticals. The company remains confident of its long-term growth aspirations as well as its margin resilience.  • Total income increased by 20.0% in Q3FY21 on account of secular growth in GDS and CMS. • Prime segment continues growth led by Levetiracetam and Mirtazapine. • Speciality business had a stable quarter led by Deferasirox and Dorzolamide. • CMS business witnessed growth in scale-up projects and higher projects coming up for validation. • Two APIs ship

Laurus Labs Ltd. –Story of Patience, diligence, and perseverance

Image
  Laurus Labs Ltd. –Story of Patience, diligence, and perseverance Twitter Handle: @shuchi_nahar Link to Company Overview of Laurus Labs in detail: https://myweekendspot.blogspot.com/2020/09/laurus-labs-company-overview.html Result Update – Q3FY21 Laurus Lab performed extremely well consecutive in the 3 rd  quarter of FY21. The company did a robust growth in all three segments. Having   a healthy order book for FY 21 & beyond in FDF CMO business with a strategic partner in EU. Consolidated revenue for the quarter increased by 76% driven by growth in all the divisions. The company has been able to sustain its EBITDA margins, and profitability has also improved to Rs. 273 Crs. for the quarter. The generic API division recorded a healthy growth of over 100% for the quarter, the growth was led by higher growth in ARV API business in turn led by higher volume of 1st line products. The Formulations business showcased a growth of over 120% for the 9M period, led by higher LMIC bus

Excel Industries - A Diversified Chemical Giant

Image
Excel Industries Ltd. - A Diversified Chemical Giant Company Overview Excel Industries Ltd., one of India’s first domestic chemical manufacturers. We are pioneers in indigenous chemical technology and sustainable waste management. Innovation has always been a key driving force at Excel. Since its inception in 1941, Today, the company is all set to embark on a new phase of meaningful growth. Excel is one of India's premier manufacturers of Specialty Polymer Additives and high-quality Veterinary APIs. The company  is all set to apply its chemical process know-how in the Pharmaceutical Intermediates industry while continuing its leadership position in agrochemical intermediates and phosphorous derivatives. Excel Industries Ltd although listed in Pesticides and Agrochemicals is a diversified company with Pharma API, Veterinary Medicine and most impotently a high potential futuristic Environment& Biotech Division. Industry Structure – Chemical Business ·         The Size of the